Hyperglycaemia and teen drivers with type 1 diabetes

Not Applicable

Recruiting

• Conditions: Type 1 Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12614001321639
• Lead Sponsor: Waikato Regional Diabetes Service, Waikato DHB

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

1.Aged between 16 and 19 years
2.Diagnosis of Type 1 Diabetes (longer than 6 months)
3.Hold a restricted or full New Zealand driver licence
4.Drive regularly (> 4 times per week)

Exclusion Criteria

1.Pregnancy
2.Regular use of illicit substances
3.Episode of Diabetic Ketoacidosis in the previous 48 hours
4.Episode of documented severe hypoglycaemia requiring assistance in the previous 24 hours

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Executive Functioning <br>As assessed by CogState Battery (5 subtests), Delis-Kaplan Executive Function System (2 subtests), and the BRIEF-SR [Both the Euglycaemic and Hyperglycaemic sessions];Driving Behaviour assessed by:<br>Stoplight task; Situation Awareness Test; and Hazard Perception Test [Both the Euglycaemic and Hyperglycaemic assessment sessions];General Cognitive Functioning as assessed by<br>Weschler Abbreviated Scale of Intelligence[Euglycaemic Session]

Secondary Outcome Measures

Name	Time	Method
Anxiety and Depression as assessed by the Hospital Anxiety and Depression Scale [Euglycaemic state];Driving Attitudes as assessed by:<br>Driver Behaviour Questionnaire; Driver Attitude Questionnaire; and Driving Self-Evaluation [Hyperglycaemic session]